PAPER Berezovska O, Jack C, McLean P, Aster JC, Hicks C, Xia W, Wolfe MS, Weinmaster G, Selkoe DJ, Hyman BT
SEARCH RESULTS
339212 RESULTS
PAPER Murphy MP, Wang R, Fraser PE, Fauq A, Golde TE
An empirical model of gamma-secretase activity.
Ann N Y Acad Sci. 2000;920:233-40. PubMed.PAPER Araki W, Yuasa K, Takeda S, Shirotani K, Takahashi K, Tabira T
Overexpression of presenilin-2 enhances apoptotic death of cultured cortical neurons.
Ann N Y Acad Sci. 2000;920:241-4. PubMed.PAPER Abraham CR, McGraw WT, Slot F, Yamin R
Alpha 1-antichymotrypsin inhibits A beta degradation in vitro and in vivo.
Ann N Y Acad Sci. 2000;920:245-8. PubMed.PAPER Arendt T, Holzer M, Stöbe A, Gärtner U, Lüth HJ, Brückner MK, Ueberham U
Activated mitogenic signaling induces a process of dedifferentiation in Alzheimer's disease that eventually results in cell death.
Ann N Y Acad Sci. 2000;920:249-55. PubMed.PAPER Hoyer S, Lee SK, Löffler T, Schliebs R
Inhibition of the neuronal insulin receptor. An in vivo model for sporadic Alzheimer disease?
Ann N Y Acad Sci. 2000;920:256-8. PubMed.PAPER Lee RK, Wurtman RJ
Regulation of APP synthesis and secretion by neuroimmunophilin ligands and cyclooxygenase inhibitors.
Ann N Y Acad Sci. 2000;920:261-8. PubMed.PAPER Hock C, Maddalena A, Heuser I, Naber D, Oertel W, von der Kammer H, Wienrich M, Raschig A, Deng M, Growdon JH, Nitsch RM
Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's disease.
Ann N Y Acad Sci. 2000;920:285-91. PubMed.PAPER Cuajungco MP, Fagét KY, Huang X, Tanzi RE, Bush AI
Metal chelation as a potential therapy for Alzheimer's disease.
Ann N Y Acad Sci. 2000;920:292-304. PubMed.PAPER Isacson O, Lin L
Cholinergic modulation of amyloid processing and dementia in animal models of Alzheimer's disease.
Ann N Y Acad Sci. 2000;920:309-14. PubMed.PAPER Fisher A, Michaelson DM, Brandeis R, Haring R, Chapman S, Pittel Z
M1 muscarinic agonists as potential disease-modifying agents in Alzheimer's disease. Rationale and perspectives.
Ann N Y Acad Sci. 2000;920:315-20. PubMed.PAPER Neary D, Snowden JS, Mann DM
Classification and description of frontotemporal dementias.
Ann N Y Acad Sci. 2000;920:46-51. PubMed.PAPER Hutton M
Molecular genetics of chromosome 17 tauopathies.
Ann N Y Acad Sci. 2000;920:63-73. PubMed.PAPER Ghiso J, Vidal R, Rostagno A, Miravalle L, Holton JL, Mead S, Révész T, Plant G, Frangione B
Amyloidogenesis in familial British dementia is associated with a genetic defect on chromosome 13.
Ann N Y Acad Sci. 2000;920:84-92. PubMed.PAPER Gómez-Tortosa E, Irizarry MC, Gómez-Isla T, Hyman BT
Clinical and neuropathological correlates of dementia with Lewy bodies.
Ann N Y Acad Sci. 2000;920:9-15. PubMed.Current Filters
No filters selected